These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31169019)

  • 21. Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis.
    Ji C; Hu J; Wang X; Zheng W; Deng X; Song H; Yu Y; Luo Q; Hua K; Zhou X; Fang L
    Aging (Albany NY); 2021 Mar; 13(7):9627-9645. PubMed ID: 33744861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis.
    Leng W; Liu Q; Zhang S; Sun D; Guo Y
    Cancer Biol Ther; 2020 Nov; 21(11):1072-1080. PubMed ID: 33138677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Troponin T1 silencing inhibits paclitaxel resistance and the development of breast cancer via suppressing rat sarcoma virus/rapidly accelerated fibrosarcoma 1 pathway.
    Zhu T; Zhou P; Yang L; Fang X; Zhi X
    Environ Toxicol; 2024 Apr; 39(4):2064-2076. PubMed ID: 38095131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway.
    Shi SL; Zhang ZH
    Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-532-5p-programmed cell death protein 4 (PDCD4) axis regulates angiotensin II-induced human umbilical vein endothelial cell apoptosis and proliferation.
    Wang Y; Gao C; Zhou K; Liu W; Zhang Y; Zhao Y
    Microvasc Res; 2021 Nov; 138():104195. PubMed ID: 34116070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway.
    Yao Y; Li X; Cheng L; Wu X; Wu B
    Bioengineered; 2021 Dec; 12(1):4032-4043. PubMed ID: 34288822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
    Sun Z; Li S; Kaufmann AM; Albers AE
    Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p.
    Li J; Fan R; Xiao H
    Cancer Cell Int; 2021 Jan; 21(1):15. PubMed ID: 33407505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-26a-5p Heightens Breast Cancer Cell Sensitivity to Paclitaxel via Targeting Flap Endonuclease 1.
    Cai Y; Zhang T; Chen G; Liu C
    Ann Clin Lab Sci; 2023 Jan; 53(1):116-125. PubMed ID: 36889769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2.
    Chen X; Zhang X; Qian Y; Xia E; Wang Y; Zhou Q
    Cell Cycle; 2022 May; 21(10):1058-1076. PubMed ID: 35184686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin.
    Du Q; Yuan Z; Huang X; Huang Y; Zhang J; Li R
    Anticancer Drugs; 2022 Mar; 33(3):308-319. PubMed ID: 34924500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer.
    Liu F; Song D; Wu Y; Liu X; Zhu J; Tang Y
    Thorac Cancer; 2017 Nov; 8(6):613-619. PubMed ID: 28842954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
    Xue D; Lu H; Xu HY; Zhou CX; He XZ
    J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells.
    Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ
    J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long Noncoding RNA
    Liu B; Luo C; Lin H; Ji X; Zhang E; Li X
    Cancer Biother Radiopharm; 2021 Aug; 36(6):456-466. PubMed ID: 32749857
    [No Abstract]   [Full Text] [Related]  

  • 37. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.
    Tan X; Li Z; Ren S; Rezaei K; Pan Q; Goldstein AT; Macri CJ; Cao D; Brem RF; Fu SW
    Breast Cancer Res; 2019 Aug; 21(1):89. PubMed ID: 31391072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
    Yang Y; Zhang G; Li J; Gong R; Wang Y; Qin Y; Ping Q; Hu L
    Pathol Res Pract; 2021 Dec; 228():153676. PubMed ID: 34753061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
    Shi YF; Lu H; Wang HB
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
    Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
    J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.